Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Brisbane Meeting - Redomicile to USA, page-54

First 54 Last

Share
Profile

Follow
Aneurysm

175 Posts.

46

29/08/23

19:03

Post #: 69620815
Share

Originally posted by SMT1994: ↑

Actually, they are recruiting for another phase 2 study: "Phase 2 Randomized Double-Blind Placebo-Controlled Multiple-Dose 3-Period Crossover Study to Compare a Fixed Dose Combination of AD816 to Viloxazine Alone and to Placebo in Obstructive Sleep Apnea"

https://clinicaltrials.gov/study/NCT05793684?term=apnimed&checkSpell=false&rank=1

Seems like the first phase 2 study didn't collect enough information to go into Pivotal studies.

Looks like INCANNEX is much more progressed

Expand

phase 3 study beginning September https://classic.clinicaltrials.gov/ct2/show/NCT05813275

looks like it’s further along than 42x.

also interesting that apnimed is a private company that has received about 200 million in venture capital.

they are also sticking to sleep apnea and not expanding into a bunch of different areas like incannex. I have to wonder why incannex wants to expand if they are so confident in 42x.

IHL Price at posting: 8.2¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

US election outcomes: Key economic and market takeaways

First 54 Last

Add IHL (ASX) to my watchlist

SPONSORED BY